Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsored by: |
Alcon Research |
---|---|
Information provided by: | Alcon Research |
ClinicalTrials.gov Identifier: | NCT00710931 |
The objective of this study is to prospectively evaluate the visual parameters in a series of patients after phacoemulsification cataract surgery in a series of patients bilaterally implanted with the AcrySof® ReSTOR® Aspheric +3.0 IOL.
Condition | Intervention | Phase |
---|---|---|
Cataract |
Device: AcrySof ReSTOR Aspheric IOL model SN6AD1 |
Phase IV |
Study Type: | Interventional |
Study Design: | Treatment, Non-Randomized, Open Label, Single Group Assignment |
Official Title: | Visual Function With Bilateral AcrySof® ReSTOR® Aspheric SN6AD1 |
Estimated Enrollment: | 40 |
Study Start Date: | September 2008 |
Estimated Study Completion Date: | April 2009 |
Estimated Primary Completion Date: | April 2009 (Final data collection date for primary outcome measure) |
Arms | Assigned Interventions |
---|---|
1: Experimental
Bilateral implantation of ReSTOR +3 IOL
|
Device: AcrySof ReSTOR Aspheric IOL model SN6AD1
Cataract implantations and multiple follow-up assessments
|
Ages Eligible for Study: | 21 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
Exclusion Criteria:
All subjects must have ≤ 0.75 diopters of astigmatism preoperatively as measured by K readings. If the surgeon determines that a correction of cylinder is necessary postoperatively, this may be performed after the three month evaluations are completed.
Responsible Party: | Alcon Laboratories, Inc. ( Myrna Bergen ) |
Study ID Numbers: | ALCONsur001.08 |
Study First Received: | July 3, 2008 |
Last Updated: | August 4, 2008 |
ClinicalTrials.gov Identifier: | NCT00710931 History of Changes |
Health Authority: | United States: Institutional Review Board |
Bilateral Cataract IOL ReSTOR Aspheric |
Eye Diseases Cataract Lens Diseases |
Eye Diseases Cataract Lens Diseases |